课题基金 / 基金详情

MECHANISMS OF PHOTORECEPTOR CELL DEGENERATION

MECHANISMS OF PHOTORECEPTOR CELL DEGENERATION
感光细胞退化的机制
批准号:
6339992
负责人:
Muna I. Naash
金额:
$15.64万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-08-01 至 2004-02-29

项目摘要

项目成果

Muna I. Naash的其他基金

相似基金

相关文献

中文摘要
翻译
编码磁盘边缘特异性蛋白的基因突变,外周蛋白/rds,与常染色体显性视网膜色素变性(ADRP)和各种形式的黄斑营养不良(MD)的发病机制有关。外周蛋白/rds在圆盘边缘结构的形成和维持中起着重要的作用。这种作用是通过与其他蛋白质的相互作用来支持的。本研究的主要目的是确定外周蛋白/rds和这些相互作用蛋白的作用和功能特性的分子基础,并研究导致人类视网膜疾病转基因模型中光感受器变性的分子异常。具体目的1、2和3是利用结构、电生理和生化研究来评估表达不同外周蛋白/rds基因突变的转基因视网膜。这些突变包括:(1)导致人类MD的ARG172TP突变,(2)决定分子间二硫键在功能性外周蛋白/rds-rom-1复合物组装中的作用的CYS214Ser突变。我们将分析这些突变对盘状膜形态发生的影响,以及外周蛋白/rds和rom-1对复合体形成的调节。我们可以通过比较Arg172Trp和Cys214Ser突变对杆状细胞和锥体外段结构和功能的影响来评价外周蛋白/rds在杆状细胞和锥体中所起的不同作用。通过比较Cys214和Cys150Ser转基因小鼠,我们将深入了解分子间和分子内二硫键形成在外周蛋白/rds功能中的作用。在第4节中,我们将使用酵母双杂交系统来确定参与外周蛋白/rds和rom-1形成多聚体复合物的相互作用位点。该系统为检测蛋白质之间的相互作用提供了强大的遗传机制。我们还将使用酵母双杂交系统筛选视网膜cDNA文库,以寻找参与功能性外周蛋白/rds-rom-1复合物组装的其他蛋白质。我们已经确定了所有已知的外周蛋白/rds与rom-1之间高度同源的区域,这些区域位于大的盘内环中。我们假设这些区域调节外周蛋白/rds-rom-1复合物之间的相互作用,并且需要保持杆盘或锥体片的扁平形状。这些相互作用可能通过亚基复合物的直接结合或通过其他蛋白质间接介导。将进行诱变研究以评估这些相互作用。这些研究将有助于深入了解外周蛋白/rds在正常和病变视网膜中的功能作用。
英文摘要
Mutations in the gene encoding the disk rim specific protein, peripherin/rds, have been implicated in the pathogenesis of both autosomal dominant retinitis pigmentosa (ADRP) and various forms of macular dystrophy (MD). Peripherin/rds plays an important role in the morphogenesis and maintenance of the disk rim structure. This role is supported by interactions with other proteins. The primary goals of the proposed research are to determine the molecular basis of action and functional properties of peripherin/rds and these interacting proteins, and to investigate the molecular abnormalities that lead to photoreceptor degeneration in transgenic models of human retinal diseases. Specific Aims 1, 2 and 3 are to use the structural, electrophysiological and biochemical studies to evaluate transgenic retinas expressing different mutations in the peripherin/rds gene. These mutations include: (1) the ARG172TP mutation that causes MD in humans, (2) the CYS214Ser mutation to determine the role of intermolecular disulfide bonds in the assembly of functional peripherin/rds-rom-1 complexes. We will analyze the effects of these mutations on morphogenesis of the disc membrane and on regulation of complex formation by peripherin/rds and rom-1. We can evaluate the different roles played by peripherin/rds in rods versus cones by comparing the effects of the Arg172Trp and Cys214Ser mutations on the structure and function of rod and cone outer segments. Comparisons of the Cys214 and Cys150Ser transgenic mice will provide insight into the role of inter- and intramolecular disulfide bond formation in peripherin/rds function. In Specific im 4, we will use a yeast two-hybrid system to identify the sites of interaction involved in formation of multimeric complexes by peripherin/rds and rom-1. This system provides a powerful genetic mechanism for detecting protein-protein interactions. We will also use the yeast two-hybrid system to screen a retinal cDNA library for other proteins that are involved in the assembly of functional peripherin/rds-rom-1 complexes. We have identified regions of high homology between all known peripherin/rds and rom-1 that are located in the large intradiscal loop. We hypothesize that these regions mediate the interactions between peripherin/rds-rom-1 complexes and are required to hold the rod discs or cone lamellae in their flattened shape. These interactions may be mediated by direct association of the subunit complexes or indirectly through other proteins. Mutagenesis studies will be performed to evaluate these interactions. These studies will provide insight into the functional role of peripherin/rds in normal and diseased retinas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vector engineering for non-viral delivery of large genomic DNA to the RPE
  • 批准号:
    10667049
  • 项目类别:
  • 资助金额:
    $23.25万
  • 财政年份:
    2023
  • 负责人:
    Muna I. Naash
  • 依托单位:
Non-viral gene delivery platforms for the treatment of Usher Syndrome Type 2A.
  • 批准号:
    10578428
  • 项目类别:
  • 资助金额:
    $40.08万
  • 财政年份:
    2023
  • 负责人:
    Muna I. Naash
  • 依托单位:
Compacted DNA Nanoparticles for Ocular Therapy
Compacted DNA Nanoparticles for Ocular Therapy
海外基金